Early immune responses accompanying human asymptomatic Ebola infections

Clinical and Experimental Immunology

Volumn 124, Issue 3, 2001, Pages 453-460

  Leroy, E M ^a   Baize, S ^a   Debre, P ^a,b   Lansoud Soukate, J ^a   Mavoungou, E ^a  

^a CENTRE INTERNATIONAL DE RECHERCHES MÉDICALES DE FRANCEVILLE   (Gabon)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Asymptomatic; Cytokine; Ebola; Immunity; TCR

Indexed keywords

CD28 ANTIGEN; CD40 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; HYDROCORTISONE; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G3; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; MESSENGER RNA; PERFORIN; RNA POLYMERASE; TUMOR NECROSIS FACTOR;

ARTICLE; CLINICAL ARTICLE; DOWN REGULATION; EBOLA VIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNITY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION; VIRION; VIRUS INFECTION;

ANTIBODIES, VIRAL; CYTOKINES; EBOLAVIRUS; HEMORRHAGIC FEVER, EBOLA; HUMANS; IMMUNOGLOBULIN G; KINETICS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; T-LYMPHOCYTES; TIME FACTORS;

EID: 0034916892     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2001.01517.x     Document Type: Article

References (50)

1. Marburg and Ebola viruses
2. Molecular biology and evolution of filoviruses
3. Clinical virology of Ebola hemorrhagic fever (EHF): Virus, virus antige , and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic Congo, 1995
4. Pathogenesis of experimental Ebola virus infection in Guinea pigs
5. Pathogenic potential of filoviruses: Role of geographic origin of primate host and virus strain
6. Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995 Determinants of survival
7. Evaluation of immune globulin and recombinant interferon-α2b for treatment of experimental Ebola virus infections
8. Filovirus-induced endothelial leakage triggered by infected monocytes/macrophages
9. Association of Ebola-related Reston virus particles and antigen with tissue lesions of monkeys imported to the United States
10. Ebola virus infection in guinea pigs: Presumable role of granulomatous inflammation in pathogenesis
11. A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever
12. Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients
13. Human asymptomatic Ebola infection exists and is associated with a strong inflammatory response
14. Detection and molecular characterization of Ebola viruses causing disease in human and nonhuman primates
15. Analysis of the Vβ specificity of superantigen activation with a rapid and sensitive method using RT PVR and an automatic DNA analyser
16. Selective depletion in HIV infection of T cells that bear specific T cell receptor Vβ sequences
17. Two serologic markers to monitor the engrafment, growth, and treatment response of human leukemias in severe combined immunodeficient mice
18. Interleukin-1 receptor antagonist reduces mortality from endotoxin shock
19. Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor
20. Interleukin-1 receptor antagonist: Role in biology
21. A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor
22. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor a in vitro and in vivo
23. Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors
24. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes
25. Net inflammatory capacity of human septic shock plasma evaluated by a monocyte-based target cell assay: Identification of interleukin-10 as a major functional deactivator of human monocytes
26. Interleukin 10 inhibits the release of CC chemokines during human endotoxemia
27. Differential regulation of lipopolysaccharide-induced interleukin 1 and tumor necrosis factor synthesis: Effects of endogenous and exogenous glucocorticoids and the role of the pituitary-adrenal axis
28. Adrenalectomy enhances proinflammatory cytokines gene expression, in the spleen, pituitary and brain of mice in response to lipopolysaccharide
29. Two inhibitors of pro-inflammatory cytokine release, interleukin-10 and interleukin-4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes
30. Interleukin-10 differentially regulates cytokine inhibitor and chemokine release from blood mononuclear cells and fibroblasts
31. Correlation between proinflammatory cytokines and antiinflammatory mediators and the severity of disease in meningococcal infections
32. The pattern of interleukin-1β (IL-1β) and its modulating agents IL-1 receptor antagonist and IL-1 soluble receptor type II in acute meningococcal infections
33. Elevated plasma levels of Tumor Necrosis Factor (TNF)-α, soluble TNF receptors, interleukin (IL) -6, and IL-10 in patients with hemorrhagic fever with renal syndrome
34. Proinflammatory cytokines and elastase-alpha-1-antitrypsin in Argentine hemorrhagic fever
35. Identification of an alternative CTLA-4 ligand costimulatory for T cell activation
36. A new member of the immunoglobulin superfamily-CTLA-4
37. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity
38. Cytolytic T-cell cytotoxicity is mediated through perforin and fas lyric pathways
39. The roles of perforin- and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses
40. Fas ligation triggers apoptosis in macrophages but not endothelial cells
41. Differential induction of apoptosis by Fas-Fas ligand interactions in human monocytes and macrophages
42. IgG subclasses to subviral components
43. Cell-dependent B cell activation
44. The role of CD40 in the regulation of humoral and cell-mediated immunity
45. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome
46. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. I. In vivo expression of CD40 ligand, cytokines, and antibody production delineates sites of cognate T-B cell interactions
47. Properties of IgG subclasses to human cytomegalovirus
48. A case of Ebola virus infection